Compare stocks

MCHX vs SOPH

Marchex, Inc. Class B and SOPHiA GENETICS SA Ordinary Shares

Compare the businesses

Marchex, Inc. Class B

Marchex, Inc., a conversation intelligence company, provides conversational analytics and related solutions in the United States, Canada, and internationally. The company's products include Marketing Edge that identifies which campaigns and channels are driving inbound conversations, evaluates what happens during those conversations, and closes the sales loop by connecting converted sales to marketing driven leads; Sonar Business Text Messaging, an artificial intelligence (AI) empowered intelligent workflow enabled mobile messaging solution that enables operations, sales, and marketing teams to communicate personally with field staff, prospects, and customers; and Marchex Platform Services, a robust API-based conversation intelligence product that allows executives, sales, customer engagement, and marketing teams to apply Marchex AI to most any calls, regardless of communication platform, to identify actionable insights from conversations with their customers. It also provides Spotlight, an AI conversation analytics product for multi-location businesses; Engage, a solution that provides locations with applications to enhance their overall performance; Call Summary and Sentiment Suite, are capabilities powered by generative AI that analyze and generate summaries of consumer-to-business calls; and AI for Industry Solution, provides automatic lead qualification, identifying high value leads with industry specific indicators to target the most valuable opportunities, and improved attribution, allowing businesses to segment audiences and improve automated bidding using attributes such as product/service, lead outcome, lead value, and topics. Marchex, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

Open MCHX dashboard ↗

SOPHiA GENETICS SA Ordinary Shares

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.

Open SOPH dashboard ↗

Sign in to keep comparing stocks

You've viewed 3 distinct stock or comparison pages today. Sign in for 10 views per day.

3 of 3 daily views used. Your allowance resets at midnight Eastern time. Refreshes and chart changes do not use another view.

Sign in →

New to NexusTrade? Create a free account.

Choose another comparison ↗